Significant Ownership of Skorpios Trust

Signature - Title
/s/ Androulla Papadopoulou - Androulla Papadopoulou, Director
Location
Limassol, Cyprus
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Skorpios Trust.

Notify me when Skorpios Trust files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Skorpios Trust

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
STOK Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.1% $29M -$12.9M 2.26M -30.7% Montrago Trustees Ltd Aug 22, 2025

Schedules 13D/G Reported by Skorpios Trust:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.